While broadly neutralizing antibodies against HIV have been shown to be important in HIV vaccine strategies, recent studies have shown that Fc mediated non-neutralizing antibodies are associated with protection against HIV and may play a role in the development of an antibody-based HIV vaccine. Here we investigated the functionality and kinetics of four Fc effector functions (Antibody-dependent neutrophil phagocytosis (ADNP), cellular phagocytosis (ADCP), complement deposition (ADCD) and Natural killer cell degranulation cytotoxicity (ADNK) in a longitudinal cohort of 53 largely MSM individuals in Coastal Kenya at 3 months, 1 year and 3.5-4 years post HIV acquisition. Additionally, using a standard neutralization assay and a global HIV pseudovirus panel, we tested for neutralizing ability 3.5-4 years post-HIV acquisition. Of the 53 participants, only 15 had detectable neutralizing activity. However, all the 4 Fc effector functions were detected in all individuals at all time points tested, with increasing activity over time. Nevertheless, only a few individuals (20) had high FC polyfunctionality. While Fc polyfunctionality was not associated with neutralizing ability, it was significantly associated with higher viremia at all the 3-time points tested. Of all Fc functions tested, only ADCP negatively correlated with viremia at 3 months post-HIV acquisition (rho= -0.46, p=0,0006). Our results show that Fc mediated functions arise early in HIV and can be sustained up to 4 years post HIV infection. Additionally, the low neutralization breadth confirms that evolution of broadly neutralizing antibodies against HIV is rare.